Inventor · disambiguated record
Sunghae Park
Also filed as: PARK SUNGHAE
8 granted patents·15 pending applications·3 citations·filing 2014–2025
77Inventor score
Top patents by PatentIndex Score
23 records- 0181US10844115B2Bone-targeting antibodiesGENZYME CORP·Filed 2018·Granted Nov 24, 2020·2 cites·6 claims
- 0280US2025074975A1Bone-Targeting AntibodiesGENZYME CORP·Filed 2024·Application pending·0 cites
- 0376US2024218051A1Modified binding polypeptides for optimized drug conjugationGENZYME CORP·Filed 2023·Application pending·0 cites
- 0476US2023126645A1Thyroid stimulating hormone compositionsGENZYME CORP·Filed 2022·Application pending·0 cites
- 0575US2025206824A1GLYCOENGINEERED Fc VARIANT POLYPEPTIDES WITH ENHANCED EFFECTOR FUNCTIONABLYNX NV·Filed 2024·Application pending·0 cites
- 0673US2023391849A1Modified binding polypeptides for optimized drug conjugationGENZYME CORP·Filed 2023·Application pending·0 cites
- 0772US2024166750A1GLYCOENGINEERED Fc VARIANT POLYPEPTIDES WITH ENHANCED EFFECTOR FUNCTIONABLYNX NV·Filed 2023·Application pending·0 cites
- 0870US12227560B2Anti-CHIKV antibodies and uses thereofSANOFI SA·Filed 2022·Granted Feb 18, 2025·0 cites·22 claims
- 0968US12098194B2Bone-targeting antibodiesGENZYME CORP·Filed 2020·Granted Sep 24, 2024·0 cites·13 claims
- 1068US11879004B2Modified binding polypeptides for optimized drug conjugationGENZYME CORP·Filed 2021·Granted Jan 23, 2024·0 cites·26 claims
- 1168US9783604B2Engineered anti-TGF-beta antibodies and antigen-binding fragmentsGENZYME CORP·Filed 2014·Granted Oct 10, 2017·1 cites·17 claims
- 1267US2025154262A1Fc DOMAIN VARIANTS WITH ENHANCED Fc RECEPTOR BINDINGABLYNX NV·Filed 2024·Application pending·0 cites
- 1365US11505611B2FGFR3 antibodies and methods of useGENZYME CORP·Filed 2021·Granted Nov 22, 2022·0 cites·16 claims
- 1465US2024279350A1CD40-Binding ProteinsSANOFI SA·Filed 2024·Application pending·0 cites
- 1565US2023303704A1Fgfr3 antibodies and methods of useGENZYME CORP·Filed 2022·Application pending·0 cites
- 1660US10730936B2Engineered anti-TGF-β antibodies and antigen-binding fragmentsGENZYME CORP·Filed 2017·Granted Aug 4, 2020·0 cites·20 claims
- 1760US2014357846A1Thyroid stimulating hormone compositionsGENZYME CORP·Filed 2014·Application pending·0 cites
- 1858US2018326082A1Thyroid stimulating hormone compositionsGENZYME CORP·Filed 2017·Application pending·0 cites
- 1957US11286295B2Anti-CHIKV monoclonal antibodies directed against the E2 structural proteinSANOFI SA·Filed 2017·Granted Mar 29, 2022·0 cites·27 claims
- 2053US2017065725A1Thyroid stimulating hormone compositionsGENZYME CORP·Filed 2016·Application pending·0 cites
- 2151US2025376511A1BINDING PROTEINS THAT TARGET aC1s, TfR, OR BOTH, AND COMPOSITIONS THEREOFGENZYME CORP·Filed 2025·Application pending·0 cites
- 2245US2018214542A1Humanized cxcr3 antibodies with depleting activity and methods of use thereofSANOFI SA·Filed 2017·Application pending·0 cites
- 2340US2018244787A1Anti-human cxcr3 antibodies for treatment of vitiligoSANOFI SA·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sunghae Park files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →